Neonatal Cystic Fibrosis Screening in Latvia: A Pilot Project

Anonymous (2009). Cystic fibrosis transmembrane conductance regulator.[PUBMED]Search in Google Scholar

Bobadilla, J., L., Farrell, M.H., Farrell, P.M. (2002). Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening. Adv. Pediatr., 49, 131-190.Search in Google Scholar

Corbetta, C., Seia, M., Bassotti, A., Ambrosioni, A., Giunta, A., Padoan, R. (2002). Screening for cystic fibrosis in newborn infants: Results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population. J. Med. Screen, 60-63.10.1136/jms.9.2.60Search in Google Scholar

Ferec, C., Casals, T., Chuzhanova, N., Macek, M., Bienvenu, T. (2006). Gross genomic rearrangements involving deletions in the CFTR gene: Characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms. Eur. J. Hum. Genet, 14, 567-576.10.1038/sj.ejhg.5201590Search in Google Scholar

Hammond, K.B., Abman, S.H., Sokol, R.J., Accurso, F.J. (1991). Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. New Eng. J. Med., 769-774.10.1056/NEJM199109123251104Search in Google Scholar

Kerem, B.S., Buchanan, J.A., Durie, P., Corey, M.L., Levison, H., Rommens, J.M., Buchwald, M., Tsui, L.C. (1989). DNA marker haplotype association with pancreatic insufficiency in cystic fibrosis. Amer. J. Hum. Genet, 44, 827-834.Search in Google Scholar

Kloosterboer, M., Hoffman, G., Rock, M., Gershan, W., Laxova, A., Li, Z., Farrell, P. (2009). Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen. Pediatrics, 338-346.10.1542/peds.2008-1681Search in Google Scholar

Krumina, A., Kroshkina, V., Krumina, L., Svabe, V., Krumina, Z., Tamane, I., Baumanis, V. (2001). Cystic fibrosis mutation dF508 in the Latvian population. RSU/AML Scientific Proceedings, 161-166.Search in Google Scholar

Loeber, J.G. (2007). Neonatal screening in Europe; the situation in 2004. J. Inherit. Metab. Dis., 30, 430-438.Search in Google Scholar

Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D. (2001). Cystic fibrosis. In: The Metabolic and Molecular bases of Inherited Disease. New York: McGraw-Hill Medical Publishing Division, 8^th edition, Vol. 3, 5121-5173.Search in Google Scholar

Sims, E.J., Clark, A., McCormick, J., Mehta, G., Connett, G., Mehta, A. (2007). United Kingdom Cystic Fibrosis Database Steering Committee. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics, 119(1), 19-28.Search in Google Scholar

Svabe, V., Krumina, A. (2001). Latvijas Cistiskās fibrozes slimnieku klīniskā stāvokła novērtējums [Evaluation of CF patients' clinical symptoms in Latvia]. RSU/AML Scientific Proceedings, 128-130.Search in Google Scholar

Wilcken, B., Wiley, V. (2003). Newborn screening methods for cystic fibrosis. Paediatr. Respir. Rev., 272-277.10.1016/S1526-0542(03)00084-8Search in Google Scholar

Znotina, I., Svabe, V., Teibe U. (2006). Cistiskās fibrozes slimnieku dzīvildzes izmaiņas Latvijā atkarībā no terapijas [Therapy influence to life expectancy of CF patients in Latvia]. RSU/AML Scientific Proceedings, 345-349.Search in Google Scholar